Longitudinal alterations of alpha-synuclein, amyloid beta, total, and phosphorylated tau in cerebrospinal fluid and correlations between their changes in Parkinson's disease M Dolatshahi, S Pourmirbabaei, A Kamalian, A Ashraf-Ganjouei, M Yaseri, ... Frontiers in neurology 9, 560, 2018 | 45 | 2018 |
Pathophysiological clues to therapeutic applications of glutamate mGlu5 receptor antagonists in levodopa-induced dyskinesia S Pourmirbabaei, M Dolatshahi, F Rahmani European Journal of Pharmacology 855, 149-159, 2019 | 24 | 2019 |
& Ranjbarian, T.(2022) A Rigi, E Ghanbarzadeh, S Pourmirbabaei, A Soleymanpour, F Taslimi, ... Clinical and Demographic Features of Burn Patients in Rasht. Updates in …, 0 | 24 | |
Clinical and Demographic Features of Burn Patients in Rasht A Rigi, E Ghanbarzadeh, S Pourmirbabaei, A Soleymanpour, F Taslimi, ... Updates in Emergency Medicine 2 (1), 60-66, 2022 | 14 | 2022 |
Clinical and Demographic Features of Burn Patients in Rasht. Updates in Emergency Medicine, 2 (1), 60–66 A Rigi, E Ghanbarzadeh, S Pourmirbabaei, A Soleymanpour, F Taslimi, ... | 14 | 2022 |
Evaluating executive functions in patients with juvenile myoclonic epilepsy using frontal assessment battery H Sanjari Moghaddam, M Doost Hoseini, MR Khaleghi, A Tafakhori, ... Behavioural neurology 2020 (1), 8710373, 2020 | 8 | 2020 |
The protective effect of probiotics on the treatment and improvement of respiratory disease caused by COVID-19 virus S Pourmirbabaei Pourmirbabaei, Shayan." The protective effect of probiotics on the treatment …, 0 | 6 | |
Efficacy of gemfibrozil as an adjunct to sertraline in major depressive disorder, a double-blind, randomized, and placebo-controlled clinical trial A Zandifar, R Badrfam, A Shamabadi, S Jalilevand, S Pourmirbabaei, ... Iranian journal of psychiatry 16 (1), 52, 2021 | 5 | 2021 |
Clinical and demographic features of Burn patients in Rasht. Updates in Emergency Medicine, 2 (1), 60-66 E Ghanbarzadeh, S Pourmirbabaei, A Soleymanpour, A Rigi, F Taslimi, ... | | 2022 |
An Exploratory Study of Associations Between longitudinal Changes of different CSF Biomarkers in Early, Drug-naiive Parkinson’s Disease Patients (P1. 011) M Dolatshahi, SS PourMirbabaei, M Yaseri, A Kamalian, MH Aarabi Neurology 88 (16_supplement), P1. 011, 2017 | | 2017 |
Longitudinal Changes in CSF Biomarkers of Parkinson’s Disease (PD) Patients (P1. 102) SS PourMirbabaei, M Dolatshahi, M Yaseri, A Kamalian, MH Arabi Neurology 88 (16_supplement), P1. 102, 2017 | | 2017 |